Wistar Scientists Identify Therapeutic Target for Epstein-Barr Virus
17 Jan 2022 //
PRESSRELEASEPOINT
Jubilant and The Wistar Insitute collaborate on potential COVID-19 treatment
18 Jan 2021 //
PHARMAFILE
17 Jan 2022 //
PRESSRELEASEPOINT
18 Jan 2021 //
PHARMAFILE